ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,023 | +41.5% | 101,750 | +12.2% | 0.78% | +53.6% |
Q2 2023 | $35,345 | +1.8% | 90,690 | -2.7% | 0.51% | 0.0% |
Q1 2023 | $34,726 | -29.9% | 93,205 | -28.7% | 0.51% | -28.1% |
Q4 2022 | $49,551 | -99.9% | 130,800 | -1.9% | 0.70% | +7.6% |
Q3 2022 | $47,070,000 | -21.7% | 133,325 | -15.9% | 0.66% | -21.8% |
Q2 2022 | $60,090,000 | +9.8% | 158,600 | -8.6% | 0.84% | +36.5% |
Q1 2022 | $54,738,000 | -30.8% | 173,600 | -23.2% | 0.61% | -12.4% |
Q4 2021 | $79,143,000 | +30.0% | 226,000 | +12.1% | 0.70% | +32.0% |
Q3 2021 | $60,883,000 | -7.7% | 201,600 | -8.0% | 0.53% | -1.7% |
Q2 2021 | $65,964,000 | -3.0% | 219,100 | -11.2% | 0.54% | -7.2% |
Q1 2021 | $67,980,000 | +640.8% | 246,850 | +691.2% | 0.58% | +676.0% |
Q4 2020 | $9,176,000 | -20.0% | 31,200 | -28.6% | 0.08% | -29.9% |
Q3 2020 | $11,472,000 | +3.5% | 43,700 | -11.2% | 0.11% | +0.9% |
Q2 2020 | $11,081,000 | -31.6% | 49,200 | -60.0% | 0.11% | -45.1% |
Q1 2020 | $16,189,000 | -9.4% | 122,895 | +10.4% | 0.19% | +21.4% |
Q4 2019 | $17,871,000 | +27.1% | 111,335 | -9.7% | 0.16% | +28.2% |
Q3 2019 | $14,058,000 | -19.8% | 123,355 | -0.3% | 0.12% | -8.1% |
Q2 2019 | $17,521,000 | +14.0% | 123,755 | +0.5% | 0.14% | +14.4% |
Q1 2019 | $15,375,000 | +24.9% | 123,155 | -3.9% | 0.12% | +11.3% |
Q4 2018 | $12,312,000 | +11.3% | 128,155 | -12.1% | 0.11% | +45.2% |
Q3 2018 | $11,062,000 | -12.2% | 145,855 | -4.1% | 0.07% | -13.1% |
Q2 2018 | $12,599,000 | -4.2% | 152,055 | -7.0% | 0.08% | -6.7% |
Q1 2018 | $13,156,000 | – | 163,555 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |